Braskem (BRKM5) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
7 Sep, 2026Executive summary
Q2 2026 saw strong operational and financial performance, with recurring EBITDA reaching US$1.043 billion, driven by higher international spreads from Middle East disruptions and positive tax credits in Brazil.
Net revenue for 2Q2026 was R$21,715 million, up 21.6% year-over-year, and net profit reached R$3,323 million, reversing a prior-year loss.
The company prioritized capital structure optimization, operational excellence, and long-term competitiveness, while advancing restructuring talks amid liquidity pressures.
Segment performance varied: Brazil/South America and US/Europe benefited from spread increases, while Mexico faced lower sales due to liquidity measures.
Material uncertainty remains regarding going concern due to negative equity, high leverage, and ongoing debt restructuring.
Financial highlights
Consolidated recurring EBITDA reached US$1.043 billion (24% margin), up from US$192 million in 1Q26; net income attributable to shareholders was US$664 million.
Net revenue was US$4.3 billion, up 46% sequentially and 37% year-over-year.
Operating cash generation was R$1,928 million, with recurring cash generation at R$1,048 million, partially offset by negative working capital variation.
Cash and cash equivalents at June 30, 2026, were R$3,931 million, down from R$10,501 million at year-end 2025.
Earnings per share (basic and diluted) for common shares reached R$5.99 for the half-year.
Outlook and guidance
Consultants and management expect normalization of spreads in H2 2026 and 2027 as product flows stabilize, but volatility may persist due to geopolitical and logistical risks.
The industry remains structurally challenged by global overcapacity, moderate demand, and ongoing macroeconomic volatility.
Regulatory measures, such as antidumping duties and sector incentives, are expected to partially mitigate competitive pressures in Brazil.
The company is prepared to capture tactical opportunities but does not expect a structural change in the industry cycle.
Latest events from Braskem
- EBITDA rose 76% sequentially, but leverage, cash burn, and legal risks remain high.BRKM5
Q1 2026 - Recurring EBITDA fell 49% and net loss reached R$10,961m amid high leverage and industry downturn.BRKM5
Q4 2025 - EBITDA surged 104% sequentially, but net loss and high leverage persisted amid legal and market headwinds.BRKM5
Q3 2025 - EBITDA plunged 67%, leverage hit 10.59x, and legal, market, and cash flow risks remain.BRKM5
Q2 2025 - 2030 targets: 1M tons each of bio-based and recycled products, with ambitious decarbonization goals.BRKM5
Investor Day 2024 - EBITDA hit a two-year high on margin gains, but legal and currency risks remain.BRKM5
Q3 2024 - EBITDA surged 39–46%, but net loss widened on currency impacts; liquidity remains strong.BRKM5
Q2 2024 - EBITDA surged 121% to US$224M, but Alagoas-related risks remain significant.BRKM5
Q1 2025 - EBITDA up 46% to US$1.1B, but FX losses led to a net loss; strong liquidity and green focus.BRKM5
Q4 2024